Credit Suisse Maintains Underperform on Fulgent Genetics, Raises Price Target to $65

Credit Suisse analyst Katie Tryhane maintains Fulgent Genetics (NASDAQ:FLGT) with a Underperform and raises the price target from $55 to $65.

Credit Suisse analyst Katie Tryhane maintains Fulgent Genetics (NASDAQ:FLGT) with a Underperform and raises the price target from $55 to $65.

Total
0
Shares
Related Posts